Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PSCA-CAR T cells in PSCA-positive metastatic castration-resistant prostate cancer; study is active not recruiting with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PSCA-CAR T cells (PSCA-CAR T cells)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-18